Health In Tech, Inc.
NASDAQ:HITSoftware - Application
+$0.00 today
- Market cap
- $50.13M
- Beta
- 2.94
- P/E (TTM)
- -75.2
- EPS (TTM)
- -$0.01
Volume 0.04M
Average 0.23M
HIT Pre-Tax Margin
Income before tax as a percentage of revenue.
Health In Tech, Inc.NASDAQ: HIT
Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026
Pre-tax margin narrows to -23.6%
Pre-tax margin was -23.6% in Q1 FY2026, down 32.1 pp from a year earlier. On a trailing-twelve-month basis it was -3.2%, down 9.3 pp year over year. Over 3 fiscal years it widened by 1.5 pp.
Context
- Pre-tax margin widened in 2 of the last 3 fiscal years.
Sources:Income StatementText generated from reported figures; not investment advice.
Pre-Tax Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 5.0%
- Year-over-year change
- +0.5pp
| Period | Period end | Pre-Tax Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.0% | +0.5pp |
| FY2024 | 2024-12-31 | 4.6% | -13.3pp |
| FY2023 | 2023-12-31 | 17.9% | +14.4pp |
| FY2022 | 2022-12-31 | 3.5% | — |
Pre-Tax Margin vs competitors
How HIT compares with its peers on the latest reported figures
- HIT's LTM Mar 2026 pre-tax margin of -3.2% is the 3rd highest of the 8 companies compared; the peer median is -35.1%.
- Its year-over-year change of -9.3 pp is the 5th highest of 8, against a peer median of -1.1 pp.
- Over three fiscal years its change of +1.5 pp compares with a peer median of +0.7 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 94.5% | +626.4 pp | +126.9 pp | |
| LTM Mar 2026 | 3.0% | -1.1 pp | +27.3 pp | |
HITHealth In Tech, Inc. | LTM Mar 2026 | -3.2% | -9.3 pp | +1.5 pp |
| LTM Mar 2026 | -12.1% | -11.5 pp | +0.7 pp | |
TEADTeads Holding Co. | LTM Mar 2026 | -35.1% | -28.8 pp | -34.9 pp |
SVCOSilvaco Group, Inc. Common Stock | LTM Mar 2026 | -46.9% | +57.0 pp | -66.0 pp |
LAWRRobot Consulting Co., Ltd. ADS | FY2025 | -79.1% | +16.4 pp | +17.9 pp |
| FY2025 | -172.0% | -39.1 pp | -161.6 pp | |
| Peer median (excluding HIT) | -35.1% | -1.1 pp | +0.7 pp | |
Competitors are the stored peer set for HIT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 5.77M | 19.15M | 19.49M | 33.33M |
| Cost of Revenue | 334.19K | 2.3M | 4.05M | 12.39M |
| Gross Profit | 5.44M | 16.85M | 15.44M | 20.94M |
| Gross Margin | 94.2% | 88.0% | 79.2% | 62.8% |
| Research & Development | 794.62K | 2M | 2.81M | 1.57M |
| Selling, General & Admin | 4.44M | 11.46M | 11.64M | 17.84M |
| Operating Expenses | 5.23M | 13.46M | 14.45M | 19.41M |
| Depreciation & Amortization | 0 | 339.3K | 541.14K | 900.58K |
| EBITDA | 205.58K | 3.76M | 1.93M | 2.57M |
| EBITDA Margin | 3.6% | 19.6% | 9.9% | 7.7% |
| Operating Income | 205.58K | 3.38M | 989.9K | 1.53M |
| Operating Margin | 3.6% | 17.7% | 5.1% | 4.6% |
| Interest Income | 0 | 40.86K | 122.89K | 409.92K |
| Interest Expense | 4.57K | 2.05K | 495K | 0 |
| Other Income / Expenses | (4.57K) | 38.81K | (100.9K) | 145.73K |
| Income Before Tax | 201.01K | 3.42M | 889K | 1.67M |
| Pre-Tax Margin | 3.5% | 17.9% | 4.6% | 5.0% |
| Income Tax Expense | 121.27K | 945.24K | 218.52K | 395.33K |
| Net Income | 79.74K | 2.48M | 670.48K | 1.28M |
| Net Margin | 1.4% | 12.9% | 3.4% | 3.8% |
| EPS (Basic) | 0.00 | 0.05 | 0.01 | 0.02 |
| EPS (Diluted) | 0.00 | 0.05 | 0.01 | 0.02 |
| Weighted Avg Shares | 54.07M | 54.07M | 67.05M | 55.84M |
| Weighted Avg Shares (Diluted) | 54.07M | 54.07M | 53.66M | 57.74M |
Health In Tech, Inc.
NASDAQ:HIT
Intrinsic Alpha fair value
Locked
Current Price
$0.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.